These 2 slides sum up my decision as a long termer rather than a ST trader especially this point "Revenue potential via licensing / partnering with pharma." Could happen any time.
Company Key Points
• Existing revenue of $7.4 million & growing
• CardioCel® to grow significantly in overseas markets
• Near term regenerative tissue product approval
• CardioCel® approved in Europe
• Differentiated via true tissue regeneration and preventing
calcification
• Early access approval already in Australia
• Significant revenue increase from a high unmet need
• Large potential with Prof Frazer’s DNA vaccine technology
• Multi-billion market potential
• Revenue potential via licensing / partnering with pharma
Milestones for Next 12 months
? Initial preclinical data for HPV vaccine program
? Additional “early access” approvals for CardioCel®
? Initial 510K US regulatory filing
? Initiation of the HSV immunotherapy Phase I study
? Approval for CardioCel® in Europe
• Initial revenues from CardioCel®
• Initial HSV-2 immunotherapy Phase I results
• Preclinical HPV results
• Approval for CardioCel® in USA
• Expanded regenerative tissue portfolio
- Forums
- ASX - By Stock
- AVR
- Ann: Investor Presentation
Ann: Investor Presentation , page-5
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 392 | $15.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.00 | 9 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 392 | 15.000 |
1 | 1000 | 14.950 |
2 | 465 | 14.600 |
1 | 50 | 14.500 |
1 | 2323 | 13.980 |
Price($) | Vol. | No. |
---|---|---|
15.000 | 9 | 1 |
15.150 | 150 | 1 |
15.300 | 167 | 1 |
15.350 | 88 | 1 |
15.400 | 63 | 2 |
Last trade - 09.40am 30/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online